Cargando…
When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
New more powerful therapies for the treatment of multiple sclerosis may also confer a potential for unprecedented life-endangering side effects. How does a physician respond to a patient’s request for a treatment the benefit of which cannot be clearly established as worth its risk? The current chall...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090283/ https://www.ncbi.nlm.nih.gov/pubmed/21573081 http://dx.doi.org/10.2147/NDT.S17522 |